§280g–3. Prescription drug monitoring program — Inbound Citations
42 U.S.C. § 280g–3
Cited by 6 provisions in release 119-102.
Citations to 42 U.S.C. § 280g–3 as a whole
-
(A) comparable to prescription drug monitoring programs operated by States, including such programs approved by the Secretary of Health and Human Services under section 399O of the Public Health Service Act (42 U.S.C. 280g–3); and
-
(1) Under regulations the Secretary shall prescribe, the Secretary shall disclose information about a covered individual to a State controlled substance monitoring program, including a program approved by the Secretary of Health and Human Services under section 399O of the Public Health Service Act (42 U.S.C. 280g–3), to the extent necessary to prevent misuse and diversion of prescription medicines.
-
(G) To a State controlled substance monitoring program, including a program approved by the Secretary of Health and Human Services under section 399O of the Public Health Service Act (42 U.S.C. 280g–3), to the extent necessary to prevent misuse and diversion of prescription medicines.
-
(xi) meeting the purpose of the program established under section 280g–3 of this title, as described in section 280g–3(a) of this title.
-
(e) For purposes of carrying out this section, section 280g–3 of this title, and section 290bb–25g of this title, there is authorized to be appropriated $505,579,000 for each of fiscal years 2026 through 2030.
Citations to §280g–3(a)
-
(xi) meeting the purpose of the program established under section 280g–3 of this title, as described in section 280g–3(a) of this title.